Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
新辅助治疗不影响 III 期非小细胞肺癌中 PD-L1 的表达:对 SAKK 16/96、16/00、16/01 和 16/14 试验肿瘤样本的回顾性分析
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2023.101595
König, D; Savic Prince, S; Hayoz, S; Zens, P; Berezowska, S; Jochum, W; Stauffer, E; Braunersreuther, V; Trachsel, B; Thierstein, S; Mark, M; Schmid, S; Curioni-Fontecedro, A; Addeo, A; Opitz, I; Guckenberger, M; Früh, M; Betticher, D C; Ris, H-B; Stupp, R; Rothschild, S I; Bubendorf, L; Pless, M